In-person

We were thrilled to co-host this event with ANVISA at ANVISA’s amphitheatre in Brasilia! This two-day event offered a great opportunity for like-minded researchers and regulators to gain a greater understanding on the new science and technologies used to address regulatory requirements. The symposium featured presentations on hot topics such as ICH M7, mutagenic impurities, degradation products and N-Nitrosamines.

We were thrilled to host an Agrochemical Industry and Regulators Symposium online and in Brazil! This one-day, hybrid event was targeted towards the agrochemical sector and provided the ideal platform for interaction and discussion between industry and regulators.

We were delighted to attend the 2022 Organic Process Research and Development Conference (OPRD). This highly anticipated event brought together industry experts to share ideas and information directly applicable to your own work. Held in Basel, Switzerland, attendees heard detailed presentations and case studies from top international chemists, discussing the latest issues relating to synthetic

We were delighted to attend the Science of Stability (SOS) Conference, which hosted in Philadelphia, USA, from 19th to 20th September 2022. Lhasa Limited, Principal Scientist, Rachel Hemingway presented a presentation at this conference.

We are thrilled to be attending International Congress of Toxicology 2022 in Maastricht, September 18th – 21st. This event is jointly organized by the International Union of Toxicology (IUTOX) and the European Society of Toxicology (EUROTOX) and unites toxicology scientists around the world. Research Leader, Katharine Briggs, will be presenting a poster; “Please, sir, I want some more…”data: Guidelines

We were delighted to attend the 2022 Safety Pharmacology Society (SPS) Annual Meeting, in Montréal. Laura Johnston, Associate Director of Applied Sciences and Adrian Fowkes, Principal Scientist attended the event. The focus of our presence at SPS was to share the exciting progress within our strategic project, Effiris – which is helping pharmaceutical organisations to anticipate and avoid adverse drug reactions through